SCHEMBL9633864

SCHEMBL9633864

CCCCOc1ccc2cc(C#N)c(C#N)cc2c1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GLA P06280 1/20 0.48
CA12 O43570 1/20 0.46
CA1 P00915 1/20 0.46
CA2 P00918 1/20 0.46
CA3 P07451 1/20 0.46
CA4 P22748 1/20 0.46
CA6 P23280 1/20 0.46
CA7 P43166 1/20 0.46
CA9 Q16790 1/20 0.46
CA14 Q9ULX7 1/20 0.46
CA5B Q9Y2D0 1/20 0.46
ALDH1A1 P00352 4/20 0.44
HPGD P15428 4/20 0.44
MEN1 O00255 1/20 0.44
NPC1 O15118 1/20 0.44
MAPT P10636 1/20 0.44
TSHR P16473 1/20 0.44
RAB9A P51151 1/20 0.44
KMT2A Q03164 1/20 0.44
AR P10275 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13822619 0.86 MAOB (0.56) ALDH1A1HPGDARKDM4EGAA
SCHEMBL29919785 0.83 CA12 (0.56) CA12CA1CA2CA3CA4
SCHEMBL15772990 0.83 CA12 (0.56) CA12CA1CA2CA3CA4
SCHEMBL347009 0.83 CA12 (0.56) CA12CA1CA2CA3CA4
SCHEMBL29779708 0.83 CA12 (0.59) CA12CA1CA2CA3CA4
SCHEMBL19809314 0.83 CA12 (0.59) CA12CA1CA2CA3CA4
SCHEMBL12190723 0.83 ALDH1A1 (0.55) ALDH1A1HPGDTSHRARKDM4E
SCHEMBL17654517 0.83 SLC6A2 (0.54) CA12CA1CA2CA3CA4
SCHEMBL11415717 0.81 ALDH1A1 (0.57) ALDH1A1HPGDTSHRARKDM4E
SCHEMBL11429810 0.81 ALDH1A1 (0.57) ALDH1A1HPGDTSHRARKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12624238-B2 Printed material YAMAMOTO CHEMICALS, INC. (JP) 2026-05-12 US disclosed
US-20240101849-A1 PRINTED MATERIAL YAMAMOTO CHEMICALS, INC. (JP) 2024-03-28 US disclosed
EP-4266212-A1 MEDIUM Yamamoto Chemicals, Inc. (JP) 2023-10-25 EP disclosed
CN-116568521-A Medium (D) 山本化成株式会社 2023-08-08 CN disclosed
WO-2022130925-A1 MEDIUM 山本化成株式会社 2022-06-23 WO disclosed
EP-0284369-B1 5- OR 6-ALKOXYCARBONYL-2,3-DICYANONAPHTHALENES AND PROCESS FOR PRODUCTION THEREOF Hitachi Chemical Co., Ltd. (JP) 1992-05-20 EP disclosed
US-4833264-A INTERMEDIATES FOR NAPHTHALOCYANINE DYES HITACHI CHEMICAL CO., LTD. (JP) 1989-05-23 US disclosed
EP-0284369-A2 5- or 6-alkoxycarbonyl-2,3-dicyanonaphthalenes and process for production thereof Hitachi Chemical Co., Ltd. (JP) 1988-09-28 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12624238-B2 Printed material CRY1, XPA, COL1A1 GLA 1529/4885CA12 15/4885CA1 91/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.